ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS)

ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) was reported 2285 times

ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRANSGENDER OPERATION 3 0.1579
1 ENDOMETRIAL THINNING 5 0.1429
2 BLINDNESS DAY 2 0.0769
3 GLOBAL LONGITUDINAL STRAIN ABNORMAL 3 0.0545
4 PHYLLODES TUMOUR 4 0.0494
5 EYELID CONTUSION 3 0.0448
6 EYELID DISCOLOURATION 2 0.0392
7 MUSCLE TENSION DYSPHONIA 3 0.0375
8 NON-PITTING OEDEMA 3 0.0341
9 RESTLESS LEG AUGMENTATION SYNDROME 4 0.0258
10 OPHTHALMIC VEIN THROMBOSIS 5 0.0207
11 OVARIAN HAEMORRHAGE 4 0.0169
12 COLD URTICARIA 3 0.0136
13 POST PROCEDURAL OEDEMA 3 0.0129
14 FAILED INDUCTION OF LABOUR 2 0.0103
15 DEAFNESS PERMANENT 2 0.0102
16 GREATER TROCHANTERIC PAIN SYNDROME 2 0.0098
17 SMOKE SENSITIVITY 3 0.0097
18 CONTRALATERAL BREAST CANCER 2 0.0097
19 FEAR OF EATING 3 0.0097
20 BLOOD OESTROGEN DECREASED 6 0.0085
21 EOSINOPHILIC PNEUMONIA ACUTE 7 0.0081
22 BENIGN LUNG NEOPLASM 2 0.0079
23 MENOPAUSAL SYMPTOMS 17 0.0073
24 DUODENOGASTRIC REFLUX 2 0.0072
25 BLOOD GROWTH HORMONE INCREASED 4 0.0072
26 CHANGE IN SUSTAINED ATTENTION 2 0.0066
27 PROGESTERONE RECEPTOR ASSAY POSITIVE 6 0.0064
28 BIOPSY BREAST 2 0.0064
29 PRODUCT INEFFECTIVE 5 0.0064
30 INTESTINAL ANGIOEDEMA 3 0.0063
31 OESTROGEN RECEPTOR ASSAY POSITIVE 7 0.0062
32 FRACTURE PAIN 3 0.0056
33 MUSCLE NECROSIS 5 0.0055
34 RECTOCELE 3 0.0050
35 FACIAL NERVE DISORDER 2 0.0045
36 HYPERTROPHIC CARDIOMYOPATHY 7 0.0045
37 BREAST CANCER FEMALE 113 0.0042
38 HEPATIC HAEMATOMA 2 0.0042
39 HAEMANGIOMA OF LIVER 4 0.0040
40 PRODUCT COMMINGLING 4 0.0038
41 VENTRICULAR HYPOKINESIA 12 0.0037
42 PERIPHERAL ARTERY THROMBOSIS 5 0.0036
43 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
44 BLOOD OESTROGEN INCREASED 2 0.0034
45 PREMATURE MENOPAUSE 3 0.0032
46 SOLAR LENTIGO 3 0.0032
47 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
48 MENOPAUSE 8 0.0031
49 PERIARTHRITIS 7 0.0031
50 STOMA COMPLICATION 3 0.0030
51 INSULIN-LIKE GROWTH FACTOR INCREASED 4 0.0028
52 THERAPEUTIC REACTION TIME DECREASED 8 0.0027
53 ATROPHIC VULVOVAGINITIS 2 0.0027
54 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
55 EPICONDYLITIS 4 0.0026
56 BREAST CANCER METASTATIC 28 0.0026
57 NEUROLOGICAL DECOMPENSATION 6 0.0026
58 LICHEN PLANUS 6 0.0026
59 BLOOD ALCOHOL INCREASED 2 0.0026
60 BREAST CALCIFICATIONS 2 0.0025
61 CHRONIC HEPATITIS 2 0.0025
62 STERNAL FRACTURE 3 0.0024
63 CORONARY ARTERY DISSECTION 2 0.0023
64 ABDOMINAL LYMPHADENOPATHY 2 0.0023
65 CYSTOCELE 2 0.0023
66 TORSADE DE POINTES 18 0.0023
67 ACROCHORDON 3 0.0023
68 SKIN DEPIGMENTATION 3 0.0022
69 SUSPECTED PRODUCT QUALITY ISSUE 4 0.0022
70 NARCOLEPSY 4 0.0021
71 EXPOSURE VIA DIRECT CONTACT 2 0.0021
72 BONE SWELLING 2 0.0021
73 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
74 URINE OUTPUT INCREASED 5 0.0019
75 ABDOMINAL MASS 5 0.0019
76 BONE NEOPLASM 2 0.0019
77 INFUSION SITE BRUISING 4 0.0019
78 CLAUSTROPHOBIA 2 0.0018
79 REACTION TO EXCIPIENT 4 0.0017
80 VOCAL CORD PARALYSIS 3 0.0017
81 UTERINE POLYP 3 0.0017
82 VULVOVAGINAL SWELLING 3 0.0016
83 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
84 BAND SENSATION 2 0.0016
85 ABNORMAL UTERINE BLEEDING 4 0.0016
86 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
87 PRODUCT ODOUR ABNORMAL 16 0.0015
88 HIRSUTISM 2 0.0015
89 HYPERLACTACIDAEMIA 4 0.0015
90 HYPERPARATHYROIDISM 3 0.0015
91 HEAD TITUBATION 2 0.0015
92 VENTRICULAR EXTRASYSTOLES 15 0.0014
93 BODY TEMPERATURE FLUCTUATION 3 0.0014
94 INTERMENSTRUAL BLEEDING 8 0.0014
95 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
96 TUMOUR HAEMORRHAGE 4 0.0014
97 LANGUAGE DISORDER 3 0.0014
98 VITAMIN B12 DECREASED 4 0.0014
99 BILIARY DILATATION 2 0.0014
100 COCCYDYNIA 2 0.0014
101 URINE ABNORMALITY 6 0.0013
102 HEAT STROKE 2 0.0013
103 PATELLA FRACTURE 3 0.0013
104 INJECTION SITE HYPERSENSITIVITY 4 0.0013
105 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
106 SKIN ODOUR ABNORMAL 5 0.0013
107 SKIN ABRASION 6 0.0013
108 CYSTITIS INTERSTITIAL 2 0.0012
109 VULVOVAGINAL DRYNESS 4 0.0012
110 SKIN FRAGILITY 3 0.0012
111 HORMONE LEVEL ABNORMAL 6 0.0012
112 PERIPHERAL ISCHAEMIA 5 0.0012
113 HEAVY MENSTRUAL BLEEDING 11 0.0012
114 HYPERNATRAEMIA 6 0.0012
115 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
116 DRUG TITRATION ERROR 3 0.0012
117 ACUTE SINUSITIS 2 0.0012
118 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
119 LUNG OPACITY 3 0.0011
120 BREAST SWELLING 3 0.0011
121 ANORGASMIA 3 0.0011
122 MIGRAINE WITH AURA 3 0.0011
123 ORAL FUNGAL INFECTION 3 0.0011
124 JAW DISORDER 6 0.0011
125 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
126 INJECTION SITE PAPULE 5 0.0011
127 TRICHORRHEXIS 3 0.0011
128 BLADDER SPASM 2 0.0011
129 PSYCHOMOTOR RETARDATION 3 0.0011
130 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
131 HEPATIC MASS 2 0.0010
132 VULVOVAGINAL PAIN 5 0.0010
133 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
134 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
135 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
136 CARDIOTOXICITY 9 0.0010
137 BREAST CANCER 94 0.0010
138 CREPITATIONS 3 0.0010
139 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
140 EAR HAEMORRHAGE 2 0.0010
141 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
142 EYE CONTUSION 2 0.0009
143 FEELING DRUNK 7 0.0009
144 TENSION HEADACHE 4 0.0009
145 BREAST ENLARGEMENT 3 0.0009
146 ONYCHOMYCOSIS 4 0.0009
147 NEAR DEATH EXPERIENCE 3 0.0009
148 CHOLESTATIC LIVER INJURY 2 0.0009
149 CALCINOSIS 2 0.0009
150 PLANTAR FASCIITIS 3 0.0009
151 METASTASES TO SPINE 3 0.0009
152 HEPATIC CYST 3 0.0009
153 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
154 MIDDLE INSOMNIA 16 0.0009
155 HANGOVER 3 0.0009
156 VAGINAL INFECTION 4 0.0008
157 VENTRICULAR TACHYCARDIA 14 0.0008
158 CONTRAST MEDIA REACTION 2 0.0008
159 DIABETES INSIPIDUS 2 0.0008
160 THROMBOCYTOSIS 3 0.0008
161 MUCOUS STOOLS 4 0.0008
162 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
163 NEURODERMATITIS 3 0.0008
164 RETINOPATHY 3 0.0008
165 ANEURYSM 4 0.0008
166 FACE INJURY 3 0.0008
167 CLAVICLE FRACTURE 3 0.0008
168 MYOSITIS 7 0.0008
169 DISEASE RECURRENCE 37 0.0008
170 AORTIC ARTERIOSCLEROSIS 2 0.0008
171 CATHETER SITE PAIN 2 0.0008
172 ORAL INFECTION 3 0.0008
173 MALABSORPTION 4 0.0008
174 BRAIN FOG 12 0.0008
175 NAIL DISCOLOURATION 3 0.0008
176 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
177 CEREBRAL ATROPHY 3 0.0008
178 HYPERPHAGIA 3 0.0008
179 SENSORY LOSS 6 0.0007
180 BREAST MASS 5 0.0007
181 SQUAMOUS CELL CARCINOMA 7 0.0007
182 APPLICATION SITE DISCOLOURATION 3 0.0007
183 ABDOMINAL RIGIDITY 2 0.0007
184 TOOTH FRACTURE 8 0.0007
185 DEFAECATION URGENCY 5 0.0007
186 ATYPICAL FEMUR FRACTURE 2 0.0007
187 TONGUE DISCOMFORT 3 0.0007
188 HOT FLUSH 53 0.0007
189 BLOOD MAGNESIUM DECREASED 6 0.0007
190 FIBULA FRACTURE 2 0.0007
191 HORDEOLUM 3 0.0007
192 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
193 DEVICE POWER SOURCE ISSUE 2 0.0007
194 URINE ODOUR ABNORMAL 4 0.0007
195 GINGIVAL SWELLING 3 0.0007
196 VULVOVAGINAL DISCOMFORT 3 0.0007
197 MIGRAINE 64 0.0007
198 SYMPTOM RECURRENCE 4 0.0007
199 IRON DEFICIENCY 3 0.0007
200 ANAL INCONTINENCE 6 0.0007
201 BREAST TENDERNESS 5 0.0007
202 VASCULAR DEVICE INFECTION 3 0.0007
203 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
204 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
205 EMBOLISM VENOUS 2 0.0007
206 EXOSTOSIS 6 0.0007
207 VULVOVAGINAL BURNING SENSATION 4 0.0007
208 DYSPAREUNIA 3 0.0007
209 BRAIN NEOPLASM 6 0.0007
210 DYSAESTHESIA 2 0.0007
211 SYNOVIAL CYST 3 0.0006
212 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
213 ARTHRITIS INFECTIVE 3 0.0006
214 VAGINAL HAEMORRHAGE 28 0.0006
215 BREAST CANCER RECURRENT 2 0.0006
216 BLADDER PAIN 2 0.0006
217 SCREAMING 4 0.0006
218 FOREIGN BODY SENSATION IN EYES 4 0.0006
219 ABSCESS 10 0.0006
220 IMPAIRED QUALITY OF LIFE 9 0.0006
221 FINGER DEFORMITY 3 0.0006
222 MYASTHENIA GRAVIS 5 0.0006
223 CARDIAC FLUTTER 4 0.0006
224 POLYP 4 0.0006
225 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
226 POOR QUALITY SLEEP 13 0.0006
227 MENSTRUAL DISORDER 5 0.0006
228 EXPIRED DEVICE USED 2 0.0006
229 POOR QUALITY DEVICE USED 6 0.0006
230 POST-TRAUMATIC STRESS DISORDER 4 0.0006
231 METASTASES TO LYMPH NODES 4 0.0006
232 VULVOVAGINAL PRURITUS 3 0.0006
233 FACIAL PARALYSIS 5 0.0006
234 EAR DISCOMFORT 6 0.0006
235 ABNORMAL DREAMS 16 0.0006
236 LYMPHOEDEMA 4 0.0006
237 HAIR GROWTH ABNORMAL 4 0.0006
238 GRANULOMA 2 0.0006
239 LARGE INTESTINE POLYP 4 0.0006
240 DIVERTICULITIS 16 0.0006
241 FORMICATION 4 0.0006
242 APHONIA 8 0.0006
243 PRODUCT AVAILABILITY ISSUE 13 0.0006
244 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
245 MUSCLE TWITCHING 13 0.0006
246 THERMAL BURN 4 0.0006
247 GASTROINTESTINAL INFECTION 5 0.0006
248 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
249 HEPATIC CYTOLYSIS 7 0.0005
250 FOOD INTOLERANCE 2 0.0005
251 RETINAL DETACHMENT 5 0.0005
252 SENSITIVE SKIN 4 0.0005
253 PSYCHIATRIC SYMPTOM 4 0.0005
254 HYPOPHOSPHATAEMIA 4 0.0005
255 INTRACRANIAL PRESSURE INCREASED 3 0.0005
256 CHRONIC SINUSITIS 2 0.0005
257 EYE INFECTION 6 0.0005
258 DYSMENORRHOEA 7 0.0005
259 IMPAIRED DRIVING ABILITY 6 0.0005
260 NIGHT SWEATS 17 0.0005
261 POISONING DELIBERATE 5 0.0005
262 ACIDOSIS 4 0.0005
263 HAIR TEXTURE ABNORMAL 7 0.0005
264 SKIN ATROPHY 3 0.0005
265 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
266 SINUS CONGESTION 7 0.0005
267 ANKLE FRACTURE 8 0.0005
268 RALES 3 0.0005
269 SKIN WARM 3 0.0005
270 MENINGIOMA 8 0.0005
271 DECREASED INTEREST 3 0.0005
272 DRUG SCREEN POSITIVE 4 0.0005
273 ODYNOPHAGIA 3 0.0005
274 OVARIAN CYST 5 0.0005
275 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
276 UTERINE CANCER 4 0.0005
277 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
278 CYSTITIS HAEMORRHAGIC 2 0.0005
279 RHINITIS 4 0.0005
280 INJECTION SITE VESICLES 3 0.0005
281 NEURALGIA 12 0.0005
282 HOMICIDAL IDEATION 2 0.0005
283 INGUINAL HERNIA 3 0.0005
284 DRY THROAT 5 0.0005
285 GOITRE 2 0.0005
286 DRUG ABUSER 3 0.0005
287 HYPERAESTHESIA 4 0.0005
288 HAIR DISORDER 4 0.0005
289 SCOLIOSIS 3 0.0005
290 HYPOKINESIA 7 0.0005
291 SWELLING OF EYELID 3 0.0005
292 BREAST PAIN 5 0.0005
293 ERUCTATION 9 0.0005
294 OSTEOPENIA 7 0.0005
295 OESOPHAGITIS 5 0.0005
296 DIVERTICULUM INTESTINAL 2 0.0005
297 DENTAL CARIES 5 0.0005
298 FOOT DEFORMITY 5 0.0005
299 RESPIRATORY RATE INCREASED 4 0.0005
300 NEEDLE ISSUE 13 0.0004
301 REBOUND EFFECT 5 0.0004
302 RESPIRATORY TRACT CONGESTION 7 0.0004
303 DRUG TOXICITY 6 0.0004
304 CRYING 16 0.0004
305 ABDOMINAL HERNIA 2 0.0004
306 RESPIRATION ABNORMAL 3 0.0004
307 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
308 MUSCLE TIGHTNESS 7 0.0004
309 THINKING ABNORMAL 8 0.0004
310 FEELING OF DESPAIR 2 0.0004
311 CARPAL TUNNEL SYNDROME 6 0.0004
312 BLOOD PROLACTIN INCREASED 2 0.0004
313 INTENTIONAL DOSE OMISSION 12 0.0004
314 DRY EYE 21 0.0004
315 METASTASIS 3 0.0004
316 SEDATION 11 0.0004
317 FEELING JITTERY 8 0.0004
318 RECALLED PRODUCT ADMINISTERED 4 0.0004
319 BLOOD CREATINE PHOSPHOKINASE INCREASED 12 0.0004
320 LOWER LIMB FRACTURE 8 0.0004
321 FAECAL INCONTINENCE 2 0.0004
322 PARAESTHESIA ORAL 6 0.0004
323 FAECES SOFT 3 0.0004
324 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
325 PANIC ATTACK 15 0.0004
326 MAJOR DEPRESSION 3 0.0004
327 COVID-19 72 0.0004
328 PARANOIA 7 0.0004
329 FLATULENCE 23 0.0004
330 TENDON RUPTURE 5 0.0004
331 FOOT OPERATION 2 0.0004
332 GENERALISED OEDEMA 5 0.0004
333 ABDOMINAL TENDERNESS 2 0.0004
334 DEVICE USE ISSUE 7 0.0004
335 FLUID INTAKE REDUCED 2 0.0004
336 AMENORRHOEA 7 0.0004
337 HEART RATE DECREASED 14 0.0004
338 HEART RATE IRREGULAR 9 0.0004
339 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
340 SLEEP DISORDER 28 0.0004
341 TENDON PAIN 3 0.0004
342 HYPOTHERMIA 4 0.0004
343 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
344 INITIAL INSOMNIA 4 0.0004
345 MYDRIASIS 5 0.0004
346 FOOD ALLERGY 3 0.0004
347 TEMPERATURE INTOLERANCE 4 0.0004
348 POOR VENOUS ACCESS 4 0.0004
349 HIATUS HERNIA 5 0.0004
350 RESTLESS LEGS SYNDROME 7 0.0004
351 NODULE 5 0.0004
352 GASTROINTESTINAL INFLAMMATION 3 0.0004
353 AFFECTIVE DISORDER 3 0.0004
354 WITHDRAWAL SYNDROME 16 0.0004
355 INJECTION SITE DISCOMFORT 4 0.0004
356 BLOOD LACTIC ACID INCREASED 2 0.0004
357 SARS-COV-2 TEST POSITIVE 5 0.0004
358 NASAL DISCOMFORT 3 0.0004
359 MOOD SWINGS 12 0.0004
360 HEPATIC STEATOSIS 7 0.0004
361 RETCHING 8 0.0004
362 MIOSIS 3 0.0004
363 FOOD POISONING 2 0.0004
364 ANAL FISSURE 2 0.0004
365 HEREDITARY ANGIOEDEMA 4 0.0004
366 EYE PAIN 21 0.0004
367 URINARY INCONTINENCE 11 0.0004
368 DECREASED ACTIVITY 4 0.0004
369 THROAT TIGHTNESS 10 0.0004
370 HIP SURGERY 2 0.0004
371 PRODUCT TASTE ABNORMAL 5 0.0004
372 POST PROCEDURAL INFECTION 3 0.0004
373 ILLNESS 38 0.0004
374 IMPAIRED GASTRIC EMPTYING 5 0.0004
375 CHOLELITHIASIS 12 0.0004
376 PRODUCT SUBSTITUTION ISSUE 21 0.0004
377 OSTEOPOROSIS 15 0.0004
378 SKIN LESION 10 0.0004
379 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
380 ABDOMINAL DISTENSION 38 0.0004
381 ASTHENOPIA 2 0.0004
382 DYSGEUSIA 27 0.0004
383 BREAST CANCER STAGE II 3 0.0004
384 DEPRESSION 82 0.0004
385 FUNGAL INFECTION 12 0.0004
386 DEPRESSED MOOD 19 0.0004
387 GAIT INABILITY 12 0.0004
388 HUNGER 5 0.0004
389 HEART RATE ABNORMAL 2 0.0004
390 INFUSION SITE ERYTHEMA 3 0.0004
391 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
392 OSTEOARTHRITIS 15 0.0004
393 SEASONAL ALLERGY 5 0.0004
394 INADEQUATE ANALGESIA 3 0.0004
395 DISTURBANCE IN ATTENTION 19 0.0004
396 MICTURITION URGENCY 4 0.0003
397 PRODUCT CONTAINER ISSUE 3 0.0003
398 HYPERSOMNIA 10 0.0003
399 HAEMATOMA 9 0.0003
400 CARDIAC MURMUR 3 0.0003
401 HYSTERECTOMY 3 0.0003
402 CYSTITIS 11 0.0003
403 INSOMNIA 92 0.0003
404 HYPERTHYROIDISM 5 0.0003
405 URINE OUTPUT DECREASED 3 0.0003
406 DYSSTASIA 10 0.0003
407 SINUSITIS 35 0.0003
408 SPINAL OSTEOARTHRITIS 3 0.0003
409 COLD SWEAT 6 0.0003
410 NASAL CONGESTION 20 0.0003
411 NECK PAIN 19 0.0003
412 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
413 HEAD DISCOMFORT 6 0.0003
414 COVID-19 PNEUMONIA 4 0.0003
415 EAR INFECTION 9 0.0003
416 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
417 CARDIAC PACEMAKER INSERTION 2 0.0003
418 FREQUENT BOWEL MOVEMENTS 9 0.0003
419 OEDEMA 18 0.0003
420 APHASIA 10 0.0003
421 MOOD ALTERED 9 0.0003
422 BURSITIS 4 0.0003
423 NOCTURIA 4 0.0003
424 DEVICE DELIVERY SYSTEM ISSUE 9 0.0003
425 DERMATITIS ACNEIFORM 2 0.0003
426 DISCOMFORT 20 0.0003
427 PNEUMONIA BACTERIAL 3 0.0003
428 ANXIETY 93 0.0003
429 IRRITABLE BOWEL SYNDROME 7 0.0003
430 BONE PAIN 19 0.0003
431 TENDONITIS 5 0.0003
432 CHOLANGITIS 2 0.0003
433 PHARYNGITIS 4 0.0003
434 TOOTH EXTRACTION 4 0.0003
435 PRODUCT PRESCRIBING ISSUE 7 0.0003
436 BASAL CELL CARCINOMA 5 0.0003
437 HEPATIC CIRRHOSIS 6 0.0003
438 FEELING ABNORMAL 76 0.0003
439 DRUG INTERACTION 50 0.0003
440 EYE INFLAMMATION 3 0.0003
441 INJECTION SITE IRRITATION 4 0.0003
442 BLOOD PRESSURE INCREASED 48 0.0003
443 SCIATICA 5 0.0003
444 COLITIS ULCERATIVE 14 0.0003
445 HYPOTHYROIDISM 10 0.0003
446 THROAT IRRITATION 14 0.0003
447 MOVEMENT DISORDER 10 0.0003
448 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
449 DYSPHONIA 18 0.0003
450 HERPES SIMPLEX 2 0.0003
451 ORAL HERPES 6 0.0003
452 PHARYNGEAL SWELLING 3 0.0003
453 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
454 VITREOUS FLOATERS 3 0.0003
455 THERAPY CHANGE 3 0.0003
456 GASTRITIS 8 0.0003
457 MANIA 5 0.0003
458 INFLUENZA LIKE ILLNESS 25 0.0003
459 DYSGRAPHIA 2 0.0003
460 ANKYLOSING SPONDYLITIS 4 0.0003
461 TOOTH INFECTION 4 0.0003
462 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
463 APPETITE DISORDER 2 0.0003
464 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
465 PRODUCT PHYSICAL ISSUE 6 0.0003
466 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
467 PRODUCT ADMINISTRATION ERROR 6 0.0003
468 ANGER 10 0.0003
469 EYE SWELLING 11 0.0003
470 ALOPECIA 58 0.0003
471 TOOTH ABSCESS 3 0.0003
472 LIMB INJURY 8 0.0003
473 PRODUCTIVE COUGH 14 0.0003
474 SCAR 5 0.0003
475 LIMB DISCOMFORT 9 0.0003
476 NERVOUS SYSTEM DISORDER 9 0.0003
477 AUTOIMMUNE HEPATITIS 2 0.0003
478 HYPERHIDROSIS 37 0.0003
479 DRUG-INDUCED LIVER INJURY 9 0.0003
480 WEIGHT FLUCTUATION 3 0.0003
481 EXTRASYSTOLES 2 0.0003
482 DERMATITIS 6 0.0003
483 SPEECH DISORDER 15 0.0003
484 SYRINGE ISSUE 5 0.0003
485 SCRATCH 3 0.0003
486 JOINT DISLOCATION 3 0.0003
487 DRY MOUTH 23 0.0003
488 NEPHROLITHIASIS 13 0.0003
489 MUSCLE SPASMS 52 0.0003
490 RENAL PAIN 3 0.0003
491 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
492 PAIN IN JAW 8 0.0003
493 HEPATOCELLULAR INJURY 4 0.0003
494 PALPITATIONS 33 0.0003
495 DIVERTICULUM 2 0.0003
496 ARTHRALGIA 117 0.0003
497 JOINT INJURY 6 0.0003
498 IMPAIRED WORK ABILITY 6 0.0003
499 AGEUSIA 7 0.0003
500 HYPOAESTHESIA 42 0.0003
501 CONTUSION 27 0.0003
502 VERTIGO 17 0.0003
503 BLOOD CHOLESTEROL INCREASED 13 0.0003
504 COGNITIVE DISORDER 13 0.0003
505 GRAFT VERSUS HOST DISEASE 2 0.0003
506 FEELING HOT 17 0.0003
507 AMNESIA 18 0.0003
508 BIPOLAR DISORDER 3 0.0003
509 SUICIDAL IDEATION 25 0.0003
510 GASTROINTESTINAL PAIN 3 0.0003
511 WEIGHT INCREASED 61 0.0003
512 APPLICATION SITE PAIN 6 0.0003
513 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
514 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
515 OROPHARYNGEAL PAIN 25 0.0003
516 ARTHROPOD BITE 2 0.0003
517 URINARY RETENTION 9 0.0003
518 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
519 VISION BLURRED 37 0.0003
520 NERVOUSNESS 14 0.0003
521 SNEEZING 6 0.0003
522 ANHEDONIA 7 0.0003
523 IRRITABILITY 16 0.0003
524 BLOOD POTASSIUM DECREASED 8 0.0003
525 CHEST DISCOMFORT 27 0.0003
526 ROAD TRAFFIC ACCIDENT 11 0.0003
527 MUSCULOSKELETAL DISORDER 5 0.0003
528 CHOLECYSTECTOMY 3 0.0003
529 HEART RATE INCREASED 26 0.0003
530 INSURANCE ISSUE 4 0.0003
531 SWELLING FACE 17 0.0003
532 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
533 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 47 0.0003
534 EYE IRRITATION 15 0.0003
535 FEAR 7 0.0003
536 HEADACHE 163 0.0003
537 THYROID DISORDER 4 0.0003
538 ATRIOVENTRICULAR BLOCK 2 0.0003
539 APHTHOUS ULCER 2 0.0003
540 VASCULITIS 3 0.0003
541 RASH MACULAR 9 0.0003
542 EAR PAIN 5 0.0003
543 APNOEA 2 0.0003
544 CHOKING 5 0.0003
545 SPINAL PAIN 3 0.0003
546 OEDEMA PERIPHERAL 31 0.0003
547 PRODUCT USE COMPLAINT 4 0.0003
548 ABDOMINAL PAIN 59 0.0003
549 BLOOD IRON DECREASED 3 0.0003
550 HEAD INJURY 8 0.0003
551 SINUS DISORDER 5 0.0003
552 FURUNCLE 2 0.0003
553 MACULAR DEGENERATION 3 0.0003
554 SPINAL FRACTURE 5 0.0002
555 SENSORY DISTURBANCE 4 0.0002
556 ADRENAL INSUFFICIENCY 3 0.0002
557 FIBROMYALGIA 6 0.0002
558 FEEDING DISORDER 5 0.0002
559 TASTE DISORDER 5 0.0002
560 FLUSHING 25 0.0002
561 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
562 GASTROINTESTINAL DISORDER 22 0.0002
563 ABDOMINAL DISCOMFORT 41 0.0002
564 ABNORMAL FAECES 2 0.0002
565 NAUSEA 193 0.0002
566 METASTASES TO BONE 4 0.0002
567 DRUG DOSE OMISSION BY DEVICE 19 0.0002
568 DIZZINESS 121 0.0002
569 BURNING SENSATION 17 0.0002
570 PHOTOSENSITIVITY REACTION 4 0.0002
571 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
572 CYST 3 0.0002
573 EOSINOPHIL COUNT INCREASED 2 0.0002
574 POLLAKIURIA 10 0.0002
575 THERAPY INTERRUPTED 17 0.0002
576 HALLUCINATION, VISUAL 5 0.0002
577 PRODUCT COMPLAINT 6 0.0002
578 EATING DISORDER 5 0.0002
579 URINARY TRACT INFECTION 40 0.0002
580 DYSPEPSIA 23 0.0002
581 INFUSION SITE PAIN 3 0.0002
582 ANOREXIA 3 0.0002
583 INFLAMMATION 12 0.0002
584 NIGHTMARE 8 0.0002
585 PAIN IN EXTREMITY 68 0.0002
586 PLATELET COUNT INCREASED 3 0.0002
587 PRODUCT DISPENSING ERROR 5 0.0002
588 BLOOD CALCIUM INCREASED 2 0.0002
589 IMMUNE SYSTEM DISORDER 3 0.0002
590 PULMONARY CONGESTION 3 0.0002
591 MALAISE 99 0.0002
592 FACIAL PAIN 2 0.0002
593 INJECTION SITE PRURITUS 15 0.0002
594 MALIGNANT MELANOMA 3 0.0002
595 PRODUCT ADHESION ISSUE 8 0.0002
596 FOREIGN BODY IN REPRODUCTIVE TRACT 2 0.0002
597 ORAL PAIN 5 0.0002
598 PAIN OF SKIN 6 0.0002
599 APPLICATION SITE PRURITUS 5 0.0002
600 DEVICE MECHANICAL ISSUE 3 0.0002
601 FATIGUE 170 0.0002
602 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
603 PRODUCT USE IN UNAPPROVED INDICATION 54 0.0002
604 TINNITUS 10 0.0002
605 SKIN DISCOLOURATION 10 0.0002
606 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
607 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
608 MUSCULOSKELETAL STIFFNESS 19 0.0002
609 PROCEDURAL PAIN 6 0.0002
610 MENTAL STATUS CHANGES 6 0.0002
611 ARTHROPATHY 12 0.0002
612 ORAL DISCOMFORT 3 0.0002
613 CONSTIPATION 47 0.0002
614 HYPERSENSITIVITY 40 0.0002
615 WEIGHT DECREASED 60 0.0002
616 MASS 3 0.0002
617 GAIT DISTURBANCE 41 0.0002
618 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
619 DEFORMITY 2 0.0002
620 SOMNOLENCE 43 0.0002
621 FLANK PAIN 2 0.0002
622 DEVICE OCCLUSION 3 0.0002
623 EYE DISORDER 7 0.0002
624 INJECTION SITE HAEMORRHAGE 17 0.0002
625 MYALGIA 36 0.0002
626 TREMOR 35 0.0002
627 BLOOD URINE PRESENT 4 0.0002
628 PROTEINURIA 4 0.0002
629 NEUROPATHY PERIPHERAL 20 0.0002
630 DEHYDRATION 28 0.0002
631 SKIN DISORDER 7 0.0002
632 SLEEP APNOEA SYNDROME 4 0.0002
633 BLOOD PRESSURE FLUCTUATION 5 0.0002
634 GLAUCOMA 4 0.0002
635 ANOSMIA 3 0.0002
636 MENTAL IMPAIRMENT 5 0.0002
637 DIZZINESS POSTURAL 2 0.0002
638 DYSTONIA 4 0.0002
639 PRESYNCOPE 5 0.0002
640 GASTROENTERITIS 3 0.0002
641 AUTOIMMUNE DISORDER 2 0.0002
642 HAEMORRHOIDS 4 0.0002
643 SKIN FISSURES 4 0.0002
644 ABDOMINAL PAIN UPPER 42 0.0002
645 KIDNEY INFECTION 4 0.0002
646 HEPATOMEGALY 2 0.0002
647 BODY TEMPERATURE DECREASED 2 0.0002
648 PSYCHOTIC DISORDER 6 0.0002
649 CARDIOMYOPATHY 3 0.0002
650 SKIN HAEMORRHAGE 3 0.0002
651 ABASIA 5 0.0002
652 BACK PAIN 47 0.0002
653 OFF LABEL USE 177 0.0002
654 EMBEDDED DEVICE 2 0.0002
655 BLADDER DISORDER 2 0.0002
656 RHINORRHOEA 13 0.0002
657 NASOPHARYNGITIS 37 0.0002
658 PRODUCT DOSE OMISSION ISSUE 59 0.0002
659 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
660 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 11 0.0002
661 BRAIN INJURY 2 0.0002
662 HYPERTENSION 42 0.0002
663 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
664 LYMPHADENOPATHY 7 0.0002
665 EYELID PTOSIS 2 0.0002
666 BALANCE DISORDER 17 0.0002
667 FLUID RETENTION 10 0.0002
668 HYPONATRAEMIA 11 0.0002
669 EUPHORIC MOOD 2 0.0002
670 PRODUCT PREPARATION ERROR 4 0.0002
671 ASTHMA 22 0.0002
672 HELICOBACTER INFECTION 2 0.0002
673 INJECTION SITE WARMTH 4 0.0002
674 RIB FRACTURE 4 0.0002
675 MUSCULOSKELETAL CHEST PAIN 3 0.0002
676 EXPOSURE VIA SKIN CONTACT 5 0.0002
677 TOOTH LOSS 4 0.0002
678 COMPLETED SUICIDE 16 0.0002
679 RESTLESSNESS 7 0.0002
680 ARTHRITIS 15 0.0002
681 JOINT STIFFNESS 5 0.0002
682 DIARRHOEA 123 0.0002
683 KNEE ARTHROPLASTY 4 0.0002
684 DEVICE ISSUE 17 0.0002
685 FULL BLOOD COUNT ABNORMAL 2 0.0002
686 CHEST PAIN 35 0.0002
687 HALLUCINATION, AUDITORY 3 0.0002
688 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
689 INJECTION SITE BRUISING 15 0.0002
690 BODY HEIGHT DECREASED 2 0.0002
691 DYSARTHRIA 7 0.0002
692 SKIN CANCER 4 0.0002
693 VISUAL IMPAIRMENT 23 0.0002
694 DEVICE MALFUNCTION 13 0.0002
695 COLITIS 7 0.0002
696 BACK DISORDER 3 0.0002
697 PARAESTHESIA 29 0.0002
698 PAIN 113 0.0002
699 BACK INJURY 2 0.0002
700 PALLOR 5 0.0002
701 MULTIPLE FRACTURES 3 0.0002
702 STAPHYLOCOCCAL INFECTION 6 0.0002
703 PRODUCT USE ISSUE 34 0.0002
704 COAGULOPATHY 3 0.0002
705 DYSPHAGIA 17 0.0002
706 VOMITING 84 0.0002
707 EYE PRURITUS 6 0.0002
708 FISTULA 2 0.0002
709 BLOOD CALCIUM DECREASED 2 0.0002
710 CANDIDA INFECTION 3 0.0002
711 CHROMATURIA 4 0.0002
712 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
713 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
714 HEPATIC ENZYME INCREASED 12 0.0002
715 MUSCULAR WEAKNESS 20 0.0002
716 DERMATITIS CONTACT 2 0.0002
717 HYPOKALAEMIA 8 0.0002
718 URTICARIA 29 0.0002
719 EYELID OEDEMA 2 0.0002
720 INTENTIONAL PRODUCT MISUSE 15 0.0002
721 SWELLING 16 0.0002
722 INCORRECT DOSE ADMINISTERED 39 0.0002
723 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
724 METASTASES TO LIVER 3 0.0002
725 SURGERY 10 0.0002
726 PANCREATITIS 9 0.0002
727 ASTHENIA 64 0.0002
728 INJECTION SITE SWELLING 13 0.0002
729 LABORATORY TEST ABNORMAL 5 0.0002
730 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
731 ARRHYTHMIA 8 0.0002
732 BACTERAEMIA 2 0.0002
733 ATAXIA 2 0.0002
734 CATARACT 10 0.0002
735 THIRST 3 0.0002
736 CHOLECYSTITIS 2 0.0002
737 MEMORY IMPAIRMENT 23 0.0002
738 MOBILITY DECREASED 12 0.0002
739 PREMATURE BABY 5 0.0002
740 RASH PRURITIC 9 0.0002
741 COMPLICATION OF DEVICE REMOVAL 3 0.0002
742 SKIN EXFOLIATION 14 0.0002
743 LEUKOCYTOSIS 3 0.0002
744 TOOTHACHE 3 0.0002
745 HEPATITIS C 2 0.0002
746 BLOOD PRESSURE DECREASED 11 0.0002
747 FALL 55 0.0002
748 END STAGE RENAL DISEASE 3 0.0002
749 HAEMATOCHEZIA 9 0.0002
750 DYSURIA 6 0.0002
751 RECTAL HAEMORRHAGE 7 0.0002
752 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
753 CARDIOMEGALY 2 0.0002
754 EMOTIONAL DISORDER 5 0.0002
755 BRONCHITIS 12 0.0002
756 ABNORMAL WEIGHT GAIN 2 0.0002
757 DEVICE LEAKAGE 7 0.0002
758 APPLICATION SITE IRRITATION 2 0.0002
759 HAIR COLOUR CHANGES 2 0.0002
760 CARDIAC DISORDER 15 0.0002
761 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
762 INTESTINAL OBSTRUCTION 6 0.0002
763 DERMATITIS ALLERGIC 2 0.0002
764 UNEVALUABLE EVENT 12 0.0002
765 RHEUMATOID ARTHRITIS 18 0.0002
766 BRAIN OEDEMA 2 0.0002
767 FOOT FRACTURE 3 0.0002
768 ABDOMINAL PAIN LOWER 4 0.0002
769 HERPES ZOSTER 9 0.0002
770 HYPOPHAGIA 4 0.0002
771 LETHARGY 9 0.0002
772 THERAPY CESSATION 8 0.0002
773 PERIPHERAL SWELLING 24 0.0002
774 HIP FRACTURE 5 0.0002
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
776 DEAFNESS 4 0.0002
777 HAND DEFORMITY 2 0.0002
778 BEDRIDDEN 2 0.0002
779 WHEEZING 9 0.0002
780 DISABILITY 3 0.0002
781 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
782 BLOOD PRESSURE ABNORMAL 3 0.0002
783 DECREASED APPETITE 35 0.0002
784 UPPER LIMB FRACTURE 3 0.0002
785 PYREXIA 52 0.0002
786 VIRAL INFECTION 5 0.0002
787 LIP SWELLING 5 0.0001
788 INJECTION SITE PAIN 46 0.0001
789 EYE HAEMORRHAGE 2 0.0001
790 JOINT SWELLING 18 0.0001
791 INTENTIONAL SELF-INJURY 3 0.0001
792 TYPE 2 DIABETES MELLITUS 5 0.0001
793 DEVICE BREAKAGE 6 0.0001
794 INJURY ASSOCIATED WITH DEVICE 3 0.0001
795 PRODUCT QUALITY ISSUE 20 0.0001
796 BLINDNESS 6 0.0001
797 SEIZURE 17 0.0001
798 MULTIPLE SCLEROSIS 7 0.0001
799 COUGH 41 0.0001
800 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
801 CHILLS 17 0.0001
802 HYPOGLYCAEMIA 7 0.0001
803 RHABDOMYOLYSIS 6 0.0001
804 FEELING COLD 4 0.0001
805 COORDINATION ABNORMAL 2 0.0001
806 BLISTER 8 0.0001
807 MOUTH ULCERATION 3 0.0001
808 BLOOD TEST ABNORMAL 2 0.0001
809 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
810 HYPOXIA 5 0.0001
811 BLINDNESS UNILATERAL 2 0.0001
812 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
813 SYNCOPE 14 0.0001
814 ANGINA PECTORIS 4 0.0001
815 ACCIDENTAL UNDERDOSE 2 0.0001
816 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
817 INFECTION 20 0.0001
818 MENTAL DISORDER 6 0.0001
819 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
820 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
821 APATHY 2 0.0001
822 INJECTION SITE ERYTHEMA 17 0.0001
823 AGITATION 10 0.0001
824 RENAL INJURY 4 0.0001
825 DRUG INTOLERANCE 13 0.0001
826 DRUG INEFFECTIVE 177 0.0001
827 HAEMORRHAGE 14 0.0001
828 BONE LOSS 2 0.0001
829 PRURITUS 51 0.0001
830 LACRIMATION INCREASED 4 0.0001
831 ECONOMIC PROBLEM 2 0.0001
832 CHRONIC KIDNEY DISEASE 10 0.0001
833 DEVICE FAILURE 2 0.0001
834 SKIN IRRITATION 6 0.0001
835 DEVICE RELATED INFECTION 2 0.0001
836 FEMUR FRACTURE 4 0.0001
837 DELUSION 2 0.0001
838 EJECTION FRACTION DECREASED 2 0.0001
839 TREATMENT NONCOMPLIANCE 7 0.0001
840 BONE DENSITY DECREASED 4 0.0001
841 DRY SKIN 17 0.0001
842 ANAPHYLACTIC REACTION 7 0.0001
843 OCULAR HYPERAEMIA 6 0.0001
844 PULMONARY EMBOLISM 12 0.0001
845 COMA 6 0.0001
846 PRODUCT PRESCRIBING ERROR 3 0.0001
847 INFLUENZA 14 0.0001
848 DRUG WITHDRAWAL SYNDROME 11 0.0001
849 METABOLIC ACIDOSIS 4 0.0001
850 CONDITION AGGRAVATED 38 0.0001
851 LOSS OF CONSCIOUSNESS 16 0.0001
852 THROMBOSIS 10 0.0001
853 TACHYCARDIA 11 0.0001
854 CONFUSIONAL STATE 20 0.0001
855 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
856 PSORIATIC ARTHROPATHY 5 0.0001
857 NEUTROPHIL COUNT DECREASED 5 0.0001
858 INJECTION SITE URTICARIA 3 0.0001
859 DEVICE DIFFICULT TO USE 8 0.0001
860 DRUG LEVEL INCREASED 2 0.0001
861 EXPIRED PRODUCT ADMINISTERED 4 0.0001
862 EPISTAXIS 9 0.0001
863 DYSPNOEA 68 0.0001
864 PNEUMONIA ASPIRATION 3 0.0001
865 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
866 ACUTE KIDNEY INJURY 18 0.0001
867 CIRCULATORY COLLAPSE 2 0.0001
868 HEPATITIS 3 0.0001
869 DRUG RESISTANCE 3 0.0001
870 INJECTION SITE REACTION 8 0.0001
871 HYPOACUSIS 5 0.0001
872 DEVICE DEFECTIVE 2 0.0001
873 DELIRIUM 4 0.0001
874 RESPIRATORY TRACT INFECTION 3 0.0001
875 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
876 ECZEMA 6 0.0001
877 MUSCULOSKELETAL PAIN 6 0.0001
878 APPLICATION SITE ERYTHEMA 3 0.0001
879 EOSINOPHILIA 2 0.0001
880 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
881 RASH 49 0.0001
882 GALLBLADDER DISORDER 2 0.0001
883 ERYTHEMA 23 0.0001
884 JAUNDICE 3 0.0001
885 ADVERSE DRUG REACTION 10 0.0001
886 BONE DISORDER 2 0.0001
887 ADVERSE EVENT 10 0.0001
888 DEEP VEIN THROMBOSIS 7 0.0001
889 DEMENTIA 3 0.0001
890 OXYGEN SATURATION DECREASED 6 0.0001
891 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
892 HALLUCINATION 8 0.0001
893 BLOOD SODIUM DECREASED 2 0.0001
894 INFUSION RELATED REACTION 7 0.0001
895 RED BLOOD CELL COUNT DECREASED 3 0.0001
896 DRUG PRESCRIBING ERROR 2 0.0001
897 ACUTE RESPIRATORY FAILURE 2 0.0001
898 PRODUCT STORAGE ERROR 9 0.0001
899 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
900 PSORIASIS 13 0.0001
901 FULL BLOOD COUNT DECREASED 2 0.0001
902 THERAPEUTIC RESPONSE DECREASED 6 0.0001
903 DYSKINESIA 4 0.0001
904 EPILEPSY 3 0.0001
905 SKIN BURNING SENSATION 7 0.0001
906 EXPOSURE DURING PREGNANCY 6 0.0001
907 UNDERDOSE 7 0.0001
908 PNEUMONIA 31 0.0001
909 CARDIO-RESPIRATORY ARREST 4 0.0001
910 TOXICITY TO VARIOUS AGENTS 16 0.0001
911 DERMATITIS ATOPIC 5 0.0001
912 HYPOTENSION 19 0.0001
913 ACNE 7 0.0001
914 BLOOD CREATININE INCREASED 6 0.0001
915 IMPAIRED HEALING 3 0.0001
916 HOSPITALISATION 14 0.0001
917 FEBRILE NEUTROPENIA 6 0.0001
918 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
919 GLOSSODYNIA 2 0.0001
920 THERAPY NON-RESPONDER 4 0.0001
921 CEREBROVASCULAR ACCIDENT 15 0.0001
922 HAEMATURIA 3 0.0001
923 GASTRIC DISORDER 3 0.0001
924 DEVICE USE ERROR 3 0.0001
925 RENAL DISORDER 4 0.0001
926 BLOOD GLUCOSE DECREASED 4 0.0001
927 EMOTIONAL DISTRESS 10 0.0001
928 STOMATITIS 5 0.0001
929 RESPIRATORY FAILURE 6 0.0001
930 INJECTION SITE MASS 3 0.0001
931 DYSPNOEA EXERTIONAL 3 0.0001
932 CELLULITIS 4 0.0001
933 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
934 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
935 DIPLOPIA 2 0.0001
936 PLASMA CELL MYELOMA 3 0.0001
937 ABNORMAL BEHAVIOUR 3 0.0001
938 RENAL FAILURE 10 0.0001
939 ABORTION SPONTANEOUS 3 0.0001
940 MYOCARDIAL INFARCTION 13 0.0001
941 CARDIAC ARREST 6 0.0001
942 TREATMENT FAILURE 6 0.0001
943 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
944 SEPSIS 8 0.0001
945 ANGIOEDEMA 3 0.0001
946 PULMONARY OEDEMA 3 0.0001
947 ILL-DEFINED DISORDER 4 0.0001
948 DIABETES MELLITUS 5 0.0001
949 GYNAECOMASTIA 2 0.0001
950 BLOOD GLUCOSE INCREASED 12 0.0001
951 RASH ERYTHEMATOUS 3 0.0001
952 THROMBOCYTOPENIA 7 0.0001
953 INTENTIONAL OVERDOSE 4 0.0001
954 PROSTATE CANCER 5 0.0001
955 NO ADVERSE EVENT 11 0.0001
956 RENAL IMPAIRMENT 5 0.0001
957 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
958 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
959 HAEMOGLOBIN DECREASED 6 0.0001
960 INJURY 4 0.0001
961 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
962 CEREBRAL HAEMORRHAGE 2 0.0001
963 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
964 DRUG EFFECT INCOMPLETE 2 0.0001
965 C-REACTIVE PROTEIN INCREASED 2 0.0001
966 DRUG DOSE OMISSION 9 0.0001
967 MEDICATION ERROR 3 0.0001
968 HEPATIC FUNCTION ABNORMAL 2 0.0001
969 CONVULSION 3 0.0001
970 ANAEMIA 10 0.0001
971 ATRIAL FIBRILLATION 5 0.0001
972 DISEASE PROGRESSION 6 0.0001
973 SUICIDE ATTEMPT 3 0.0000
974 EXTRA DOSE ADMINISTERED 2 0.0000
975 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
976 DRUG ABUSE 4 0.0000
977 DEVICE EXPULSION 3 0.0000
978 NEOPLASM MALIGNANT 3 0.0000
979 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
980 COLORECTAL CANCER 2 0.0000
981 AGGRESSION 2 0.0000
982 BRADYCARDIA 2 0.0000
983 PLATELET COUNT DECREASED 4 0.0000
984 CARDIAC FAILURE 3 0.0000
985 CARDIAC FAILURE CONGESTIVE 3 0.0000
986 DRUG EFFECT DECREASED 2 0.0000
987 OVERDOSE 7 0.0000
988 DRUG DEPENDENCE 5 0.0000
989 NEUTROPENIA 4 0.0000
990 DEATH 23 0.0000